Stockscreener 앱 받기
3.30
0.61%
0.02
시간 외 거래:
3.27
-0.03
-0.91%
전일 마감가:
$3.28
열려 있는:
$3.31
하루 거래량:
63,036
Relative Volume:
0.48
시가총액:
$12.35M
수익:
$36.12M
순이익/손실:
$-232.49M
주가수익비율:
-0.1856
EPS:
-17.78
순현금흐름:
$-126.87M
1주 성능:
+1.54%
1개월 성능:
-10.08%
6개월 성능:
-80.93%
1년 성능:
-91.70%
1일 변동 폭
$3.25
$3.395
1주일 범위
$3.18
$3.47
52주 변동 폭
$2.68
$41.33
바이오나노 지노믹스 Stock (BNGO) Company Profile
명칭
Bionano Genomics Inc
전화
(858) 888-7600
주소
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
BNGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
3.30 | 12.35M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
537.99 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.67 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.02 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.26 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.42 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
바이오나노 지노믹스 Stock (BNGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-12 | 재개 | BTIG Research | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2021-06-16 | 개시 | BTIG Research | Buy |
| 2020-09-24 | 개시 | Ladenburg Thalmann | Buy |
| 2020-04-08 | 개시 | Oppenheimer | Outperform |
모두보기
바이오나노 지노믹스 주식(BNGO)의 최신 뉴스
21 Global Studies Validate Bionano Optical Genome Mapping at Major EU Genetics Conference | BNGO Stock News - Stock Titan
Bionano Genomics, Inc. (NASDAQ:BNGO) Given Average Recommendation of “Hold” by Analysts - Defense World
BioNano Genomics Enhances Governance with New Appointment - TipRanks
(BNGO) Investment Analysis and Advice - news.stocktradersdaily.com
410,469 Shares in Bionano Genomics, Inc. (NASDAQ:BNGO) Acquired by Jane Street Group LLC - Defense World
Northern Trust Corp Sells 11,004 Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
How To Trade (BNGO) - news.stocktradersdaily.com
Bionano Genomics stock rises on Q1 revenue beat - MSN
Bionano Genomics, Inc. (NASDAQ:BNGO) Given Average Rating of “Hold” by Analysts - Defense World
Bionano Genomics (NASDAQ:BNGO) Stock Rating Upgraded by Wall Street Zen - Defense World
Maxim Group Upgrades Bionano Genomics (NASDAQ:BNGO) to Buy - Defense World
Maxim Group Upgrades Bionano Genomics (BMV:BNGO) - Nasdaq
Maxim Group Upgrades Bionano Genomics (LSE:0A4K) - Nasdaq
Maxim Group Upgrades Bionano Genomics (BNGO) - Nasdaq
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upg - GuruFocus
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upgrade | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brighten | BNGO Stock News - GuruFocus
Maxim Upgrades Bionano Genomics to Buy From Hold, $8 Price Target - marketscreener.com
Bionano (BNGO) Achieves Milestone with New CPT Code for Genetic - GuruFocus
(BNGO) Long Term Investment Analysis - news.stocktradersdaily.com
Bionano Laboratories Announces a Second Category I CPT Code - GlobeNewswire
Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders - Yahoo Finance
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2025 Earnings Call Transcript - Insider Monkey
Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more - MSN
Biggest stock movers Thursday: CSCO, FL, BABA, BNGO, and more - MSN
Biggest stock movers Thursday: CSCO, BNGO, and more - MSN
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Na - GuruFocus
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Q1 2025 Earnings Call Transcript - MarketBeat
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 202 - GuruFocus
Bionano Genomics Retail Mood Turns ‘Extremely Bearish’ Amid Revenue Guidance Shortfall - Asianet Newsable
Bionano Genomics (BNGO) Refocuses Strategy Amid Revenue Dip - GuruFocus
Bionano outlines $26M–$30M 2025 revenue target as strategic pivot drives higher gross margin - MSN
Earnings call transcript: Bionano Genomics Q1 2025 sees revenue drop, stock surges - Investing.com
Bionano Genomics (BNGO) Sees Strategic Shift Boost in Q1 2025 | - GuruFocus
Bionano Genomics Q1 2025 Earnings: Revenue Beats Estimates at $6 - GuruFocus
Bionano Genomics stock rises on Q1 revenue beat (BNGO:NASDAQ) - Seeking Alpha
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 2025 | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Forecasts Lower Q2 Revenue Than Expected - GuruFocus
Bionano Genomics (BNGO) Forecasts Lower Q2 Revenue Than Expected | BNGO Stock News - GuruFocus
Bionano Genomics Q1 2025 Financial Results - TradingView
A Glimpse of Bionano Genomics's Earnings Potential - Nasdaq
Bionano Genomics (BNGO) Boosts Cancer Diagnostics with New Study - GuruFocus
Bionano Genomics (BNGO) Boosts Cancer Diagnostics with New Study Findings | BNGO Stock News - GuruFocus
Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies - The Manila Times
Bionano Laboratories Announces Publication of the Largest - GlobeNewswire
Bionano Genomics (BNGO) Projected to Post Earnings on Wednesday - The AM Reporter
Bionano Genomics (BNGO) to Release Quarterly Earnings on Wednesday - Defense World
When (BNGO) Moves Investors should Listen - news.stocktradersdaily.com
바이오나노 지노믹스 (BNGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.70%
자본화:
|
볼륨(24시간):